Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib

Cancers, Free Full-Text

PDF] Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

POR Mutation Spectrum of EGFR From 21,324 Chinese Patients With Non-Small Cell Lung Cancer (NSCLC) Successfully Tested by Multiple Methods in a CAP-Accredited Laboratory

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Cancers, Free Full-Text

Cancers, Free Full-Text

Frontiers Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies